Company: PTHS
Filing Date: 2025-11-14
Form Type: PRE 14A
Source: 0001753926-25-001803
Chunk: 0

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-11-14
Form: PRE 14A
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

(RULE 14a-101)

SCHEDULE 14A INFORMATION

PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934

(AMENDMENT NO. )</div>

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

| ☒ | Preliminary     
 Proxy Statement |

| ☐ | Confidential,                                                     
 For Use of the Commission Only (as Permitted by Rule 14a-6(e)(2)) |

| ☐ | Definitive      
 Proxy Statement |

| ☐ | Definitive           
 Additional Materials |

| ☐ | Soliciting                 
 Material under §240.14a-12 |

| Pelthos                                                            
 Therapeutics Inc.                                                  |
| (Name                                                              
 of Registrant as Specified In Its Charter)                         |
| (Name                                                              
 of Person(s) Filing Proxy Statement, if other than the Registrant) |

Payment of Filing Fee (Check the appropriate box):

| ☒ | No           
 fee required |

| ☐ | Fee                                         
 paid previously with preliminary materials. |

| ☐ | Fee                                                                                             
 computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11. |

<div align='center'>PRELIMINARY PROXY STATEMENT — SUBJECT TO COMPLETION, DATED NOVEMBER 14, 2025

4020 Stirrup Creek Drive, Suite 110

Durham, NC

(919) 908-2400

Important Notice Regarding the Availability of Proxy Materials

for the Annual Meeting of Shareholders to Be Held on December 17, 2025

The Notice of Annual Meeting, Proxy Statement

and Annual Report on Form 10-K are available at:

www.proxyvote.com

NOTICE OF ANNUAL MEETING OF SHAREHOLDERS

TO BE HELD ON DECEMBER 17, 2025</div>

To the Shareholders of Pelthos Therapeutics Inc.:

NOTICE IS HEREBY GIVENthat the 2025 Annual Meeting of Shareholders (the “Annual Meeting”) of Pelthos Therapeutics Inc. (the “Company”) will be held online on December 17,